UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000059587 |
|---|---|
| Receipt number | R000068156 |
| Scientific Title | Network Meta-analysis of Partial Nephrectomy and Ablative Therapies for Renal Tumor <=3 cm |
| Date of disclosure of the study information | 2025/10/30 |
| Last modified on | 2025/10/29 21:13:06 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Network Meta-analysis of Partial Nephrectomy and Ablative Therapies for Renal Tumor <=3 cm
Acronym
Network Meta-analysis of Partial Nephrectomy and Ablative Therapies for Renal Tumor <=3 cm
Scientific Title
Network Meta-analysis of Partial Nephrectomy and Ablative Therapies for Renal Tumor <=3 cm
Scientific Title:Acronym
Network Meta-analysis of Partial Nephrectomy and Ablative Therapies for Renal Tumor <=3 cm
Region
| Japan |
Condition
Condition
Renal tumor
Classification by specialty
| Radiology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
This study aimed to perform a network meta-analysis comparing partial nephrectomy, radiofrequency ablation, cryoablation, and microwave ablation in patients with renal tumors <=3 cm, in order to provide evidence to guide optimal treatment selection by evaluating oncological and safety outcomes.
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
local recurrence risk, all-cause mortality, cancer-specific mortality, complication rate
Key secondary outcomes
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Studies including patients with cT1a or cT1b renal tumors.
Studies comparing partial nephrectomy and/or ablative therapies (radiofrequency ablation, cryoablation, or microwave ablation).
Studies reporting outcomes related to recurrence, survival, complication rate, or renal function.
Key exclusion criteria
Case reports, review articles, letters, meta-analyses.
Studies with no available outcome data.
Non-human studies.
Subgroup or secondary analyses.
Duplicate or overlapping patient cohorts.
Studies published in languages other than English.
Target sample size
Research contact person
Name of lead principal investigator
| 1st name | Shingo |
| Middle name | |
| Last name | Koyama |
Organization
Yokohama City University Hospital
Division name
Diagnostic Radiology
Zip code
236-0004
Address
3-9 Fukuura, Kanazawa-ku, Yokohama, Japan
TEL
+8145-787-2800
singo109@yokohama-cu.ac.jp
Public contact
Name of contact person
| 1st name | Shingo |
| Middle name | |
| Last name | Koyama |
Organization
Yokohama City University Hospital
Division name
Diagnostic Radiology
Zip code
236-0004
Address
3-9 Fukuura, Kanazawa-ku, Yokohama, Japan
TEL
+8145-787-2800
Homepage URL
singo109@yokohama-cu.ac.jp
Sponsor or person
Institute
Yokohama City University
Diagnostic Radiology
Shingo Koyama
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Yokohama City University
Address
3-9 Fukuura, Kanazawa-ku, Yokohama, Japan
Tel
+8145-787-2800
singo109@yokohama-cu.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2025 | Year | 10 | Month | 30 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2025 | Year | 10 | Month | 29 | Day |
Date of IRB
| 2025 | Year | 10 | Month | 29 | Day |
Anticipated trial start date
| 2025 | Year | 10 | Month | 29 | Day |
Last follow-up date
| 2026 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
This study is a network meta-analysis comparing the treatment outcomes of partial nephrectomy and ablative therapies for renal tumors. It is an observational study based on previously published literature, without any new interventions or patient data collection. As the analysis uses publicly available data, there is no ethical risk, and ethical review was deemed unnecessary. This registration is intended to ensure the transparency and reproducibility of the research. No specific funding was received, and there are no conflicts of interest. The study will be conducted in accordance with the PRISMA 2020 statement and the MOOSE guidelines.
Management information
Registered date
| 2025 | Year | 10 | Month | 29 | Day |
Last modified on
| 2025 | Year | 10 | Month | 29 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068156
